US ties Zambia's HIV funding to critical minerals access

LUSAKA — At the centre of Zambia’s HIV response is a US demand that the country grant American firms expanded minerals access or forfeit remaining American support for HIV treatment.

The stakes are immediate for a programme that keeps about 1.3 million Zambians on treatment. Health Policy Watch reported that Washington set a 30 April 2026 deadline for a minerals-tied agreement, after which all US support for the HIV programme would end. The arrangement ties access to Zambia’s copper, cobalt and lithium to the funding that sustains antiretroviral care, putting a core part of Zambia’s health system in the balance.

Health Policy Watch reported on 25 April 2026 that the United States warned Zambia all American support for its HIV programme would end without a minerals-tied agreement signed by 30 April 2026. The reported terms made continued health assistance conditional on expanded American access to the country’s critical minerals.

Snopes reported that about 1.3 million Zambians rely on HIV and antiretroviral treatment supported by the President’s Emergency Plan for AIDS Relief, the long-running US programme known as PEPFAR. The scale of that dependence is what gives the deadline its weight: a lapse would touch the supply of the medicines that keep people alive.

Snopes reported that a United States Department of State memo proposed roughly US$1 billion of US health support over five years, less than half of Zambia’s pre-2025 American health assistance. The same reporting noted that the US had committed US$367 million to Zambia’s HIV response for 2025, a benchmark against which the proposed five-year figure looks sharply reduced. The earlier reporting on the regional retreat in aid is detailed by Washington’s decision to end PEPFAR support for South Africa, which has tracked a similar pressure across the region.

Snopes reported that index testing, an approach that had identified about 70% of new HIV infections each year, was shut down amid the funding cuts. Index testing traces the partners and contacts of people who test positive, and its closure removes one of the most efficient tools for finding new cases before they spread.

The contraction sits within a wider drawdown that Zambian officials have been trying to manage. Reporting on the state of play noted that a fresh US health grant has been discussed but not concluded; coverage of the unsigned US health grant to Zambia sets out the government’s position that no replacement deal had yet been signed.

About 1.3 million Zambians rely on PEPFAR-supported HIV and antiretroviral treatment — the scale of dependence behind the 30 April 2026 deadline.

— Reported by Snopes, 3 May 2026 — <a href="https://www.snopes.com/news/2026/05/03/trump-zambia-mineral-rights-his-aids-meds/">snopes.com</a>

Background

PEPFAR has underwritten HIV treatment, testing and prevention across Zambia for two decades, and the US Embassy in Zambia describes the programme as a pillar of the country’s response. The shift to conditionality marks a sharp turn from that record: the question moved from how much the US would give to what Zambia would have to concede in minerals to keep receiving it.

Zambia is one of Africa’s largest copper producers and holds cobalt and lithium reserves that have drawn intense interest as the world races to secure inputs for batteries and clean-energy technology. Snopes reported that the proposed US health support of roughly US$1 billion over five years amounted to less than half of Zambia’s pre-2025 American health assistance, framing the offer as a reduction wrapped in a resource demand.

What to watch

The first marker is the 30 April 2026 deadline that Health Policy Watch reported, and whether any minerals-tied agreement was concluded around it. The terms of any deal, and the size of US health support attached to it, will signal how far the conditionality reshapes Zambia’s HIV financing.

The second marker is the effect on services already curtailed. Snopes reported that index testing, which had found about 70% of new infections each year, was shut down amid the cuts; whether that capacity is restored, and how the Ministry of Health and partners such as UNAIDS fill the gap, will determine the human cost of the funding squeeze.

Frequently Asked Questions

These are the questions readers have been asking about the US funding pressure on Zambia’s HIV programme. Short answers follow, drawn from the reporting in the public record.

What did the US ask Zambia to do?

In short, the US tied continued health support to minerals. According to Health Policy Watch, Washington warned that all US support for Zambia’s HIV programme would end without a minerals-tied agreement signed by 30 April 2026, linking the funding to expanded American access to copper, cobalt and lithium. The evidence points to conditionality rather than a straightforward grant.

How many people depend on the HIV programme?

Simply put, about 1.3 million people. Snopes reported that roughly 1.3 million Zambians rely on HIV and antiretroviral treatment supported by PEPFAR, which is why the deadline drew such concern. Data on that dependence shows how widely a funding lapse would be felt.

How much US money was on the table?

The answer is two numbers. Snopes reported that the US had committed US$367 million to Zambia’s HIV response for 2025, and that a State Department memo proposed roughly US$1 billion over five years, which analysis described as less than half of Zambia’s pre-2025 American health assistance. The figures reveal a proposed reduction alongside the minerals demand.

What is index testing and why does its closure matter?

In other words, index testing is a way of finding new cases by tracing the contacts of people who test positive. Snopes reported that index testing, which had identified about 70% of new HIV infections each year, was shut down amid the funding cuts; research and programme data show such tracing is among the most efficient tools for catching infections early.

What happens next for Zambia’s HIV response?

The key is whether replacement financing is secured. According to the reporting, a fresh US health grant had been discussed but not signed, leaving the Ministry of Health, the Ministry of Health’s partners and bodies such as UNAIDS to manage the shortfall; the evidence suggests the outcome hinges on the terms of any minerals-tied deal and on domestic financing choices, including the case made in coverage of the fiscal case for health taxes in Zambia.

Sources

Primary reporting: Health Policy Watch on the US health-deal pressure on Zambia and South Africa, and Snopes on the reported minerals-for-medicine demand. Programme background: the US Embassy in Zambia on PEPFAR. Related Kwacha News coverage: Washington ending PEPFAR support for South Africa and the unsigned US health grant to Zambia.